Genix Pharmaceuticals 

$0.015100
1
+$0.00+7.09% Wednesday 13:30

Statistics

Day High
0.0138
Day Low
0.0138
52W High
0.03573
52W Low
0.0138
Volume
69
Avg. Volume
129
Mkt Cap
924,482.4
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31JulExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
-0
-0
0
Expected EPS
0
Actual EPS
-0.0066

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-476,804.69Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GENPF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in the Canadian market is on nutraceuticals and pharmaceuticals. Their product pipeline features several key developments: Flu-X: An herbal treatment available as an oral solution or spray, targeting viral infections, influenza, and coronaviruses responsible for common colds. Renochlor: A nutritional supplement formulated to support the revitalization and maintenance of kidney health and function. Sucanon: An insulin sensitizer designed to reduce blood sugar by improving the sensitivity of muscle, fat, and liver cells to insulin. Beyond these, Genix Pharmaceuticals also offers a wide range of other nutraceuticals and pharmaceutical items. This selection includes supplements such as bee propolis capsules, liquid calcium softgels, seal oil softgels, marine lipid softgels, lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, alongside ophthalmic products like eye ointments and drops. The company operated under the name Alta Natural Herbs & Supplements Ltd. until it adopted its current identity, Genix Pharmaceuticals Corporation, in June 2019.
Show more...
CEO
Ms. Raylen Tamayo
Employees
4000
Country
Canada
ISIN
CA37232A1093

Listings

0 Comments

Share your thoughts

FAQ

What is Genix Pharmaceuticals stock price today?
The current price of GENPF is $0.02 USD — it has increased by +7.09% in the past 24 hours. Watch Genix Pharmaceuticals stock price performance more closely on the chart.
What is Genix Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genix Pharmaceuticals stocks are traded under the ticker GENPF.
Is Genix Pharmaceuticals stock price growing?
GENPF stock has risen by +7.09% compared to the previous week, the month change is a +7.09% rise, over the last year Genix Pharmaceuticals has showed a +9.42% increase.
What is Genix Pharmaceuticals market cap?
Today Genix Pharmaceuticals has the market capitalization of 924,482.4
What were Genix Pharmaceuticals earnings last quarter?
GENPF earnings for the last quarter are -0.01 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genix Pharmaceuticals revenue for the last year?
Genix Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Genix Pharmaceuticals net income for the last year?
GENPF net income for the last year is -476,804.69 USD.
How many employees does Genix Pharmaceuticals have?
As of June 28, 2026, the company has 4,000 employees.
In which sector is Genix Pharmaceuticals located?
Genix Pharmaceuticals operates in the Health & Wellness sector.
When did Genix Pharmaceuticals complete a stock split?
Genix Pharmaceuticals has not had any recent stock splits.
Where is Genix Pharmaceuticals headquartered?
Genix Pharmaceuticals is headquartered in Vancouver, Canada.